InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the full record of transactions filed by Smither John W, Director. Officer active across 5 companies, notably eFFECTOR Therapeutics, Inc.. Aggregated, 11 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €17k. Activity tracked since 11 September 2023. The latest transaction was filed on 3 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Smither John W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
28,000 shares0Common StockSEC:0001193125-26-331642:0
28,409 sharesCommon StockSEC:0001493152-26-029413:0
3,400 sharesOrdinary SharesSEC:0001193125-26-009270:0
22,283 shares0Common StockSEC:0001641172-25-026005:0
6,960 sharesOrdinary SharesSEC:0000950170-25-003570:0
39,541 shares0Common StockSEC:0001415889-24-020778:0
6,250 sharesCommon StockSEC:0001415889-24-016109:0
Canonical exit: 27 Aug 2024 (T+90)
2,793 sharesCommon StockSEC:0001787306-24-000014:0
900 shares@ US$20.78100.0% of flowCommon StockSEC:0001209191-23-049519:0
6,920 shares0Common StockSEC:0001209191-23-049364:0
24,142 sharesCommon StockSEC:0001209191-21-053707:0
11 of 11 declarations
About Smither John W
Smither John W is Administrateur. He has 11 filings in total, and in the recent filings available, the reported sell amount totals EUR 17423, with the first filing dated 2021-08-27 and the last dated 2026-08-04. The companies listed are GENELUX CORP, NewAmsterdam Pharma Co N.V., MBX Biosciences, Inc., Arcutis Biotherapeutics, Inc. and eFFECTOR Therapeutics, Inc.
